Discussion: Also it was found that the frequencies of
T216C,
G1896A,
G1913A/G, and
A2159G/C were >45% in the patients with
ACLF, the combinative mutations at these sites could be utilized to diagnose clinically and to discriminate the
HBV-infected patients with
advanced disease.